logo
episode-header-image
Apr 2024
11m 27s

EMPACT-MI Results: Empagliflozin After ...

AMERICAN COLLEGE OF CARDIOLOGY
About this episode

Patients with acute myocardial infarction are at a high risk of heart failure and death. Despite advances in care and reduction in the rate of recurrent myocardial infarctions, the risk for heart failure continues to be unacceptably high. No intervention in 2 decades has been shown to improve this risk. 

 In this interview, Javed Butler, MD, MPH, MBA, and Sun Moon Kim, MD, FACC, discuss the results of the EMPACT-MI trial. 

Up next
Jul 8
Putting it All Together: Cardiogenic Shock Management in 2025
Cardiogenic shock remains a critical, time-sensitive emergency with a high mortality rate. However, recent advances—particularly multidisciplinary, team-based strategies—have shown promise in improving patient outcomes. With the release of the 2025 ACC Concise Clinical Guidance o ... Show More
11m 57s
Jul 1
Hemodynamic Assessment for Diagnosis and Treatment Selection in HFpEF
Heart failure arises when the heart is unable to pump or fill with blood effectively. In the cardiac catheterization lab, we have the unique ability to directly measure the physiological abnormalities underlying this condition, making it the gold standard for diagnosing heart fai ... Show More
11m 2s
Jun 24
Primary Results From the SOUL Randomized Trial
The SOUL trial demonstrated that in patients with type 2 diabetes (T2DM) and established atherosclerotic cardiovascular disease (ASCVD), chronic kidney disease (CKD), or both, treatment with oral semaglutide significantly reduced the risk of major adverse cardiovascular events (M ... Show More
12m 13s
Recommended Episodes
Oct 2023
Risk of Stroke, Myocardial Infarction, and Death After Retinal Artery Occlusion
Interview with Prithvi Mruthyunjaya, MD, MHS, author of Risk of Stroke, Myocardial Infarction, and Death After Retinal Artery Occlusion. Hosted by Neil M. Bressler, MD. Related Content: Risk of Stroke, Myocardial Infarction, and Death After Retinal Artery Occlusion 
16m 36s
Jul 2022
224. Atrial Fibrillation: Assessment of Stroke & Bleeding Risk with Dr. Elaine Hylek
CardioNerds (Amit Goyal), Dr. Colin Blumenthal (CardioNerds Academy House Faculty Leader and FIT at the University of Pennsylvania), and Dr. Anjali Wagle (CardioNerds Ambassador and FIT at Johns Hopkins University), discuss the baseline assessment of stroke and bleeding risk in p ... Show More
1h 15m
Aug 2023
323. Beyond the Boards: Complications of Acute Myocardial Infarction with Dr. Jeffrey Geske
CardioNerds co-founder Dr. Amit Goyal and episode leads Dr. Jaya Kanduri (FIT Ambassador from Cornell University) and Dr. Jenna Skowronski (FIT Ambassador from UPMC) discuss Complications of acute myocardial infarction with expert faculty Dr. Jeffrey Geske. They discuss various c ... Show More
30m 49s
Oct 2023
341. Guidelines: 2021 ESC Cardiovascular Prevention – Question #35 with Dr. Melissa Tracy
The following question refers to Section 4.9 of the 2021 ESC CV Prevention Guidelines. The question is asked by Dr. Christian Faaborg-Andersen, answered first by UCSD fellow Dr. Patrick Azcarate, and then by expert faculty Dr. Melissa Tracy. Dr. Tracy is a preventive cardiologist ... Show More
7m 5s
Jul 2023
316. Guidelines: 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure – Question #24 with Dr. Ileana Pina
The following question refers to Sections 10.2 of the 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. The question is asked by Western Michigan University medical student and CardioNerds Intern Shivani Reddy, answered first by Mayo Clinic Cardiology Fellow and Ca ... Show More
10m 54s
Jul 2022
223. CCC: Approach to Acute Myocardial Infarction Cardiogenic Shock with Dr. Venu Menon
With the advent and rapid evolution of contemporary percutaneous coronary intervention (PCI), the early invasive management of acute myocardial infarction (AMI) has become a mainstay in therapy with significant impact on patient outcomes. However, despite modern advances in techn ... Show More
47m 56s
Jun 2023
309. Atrial Fibrillation: Situational Assessment of Stroke and Bleeding Risk with Dr. Hafiza Khan
Dr. Daniel Ambinder (CardioNerds Co-Founder), Dr. Kelly Arps (Series Co-Chair and EP fellow at Duke University), Dr. Stephanie Fuentes Rojas (FIT Lead and EP fellow at Houston Methodist), and Dr. Ingrid Hsiung (Cardiology Fellow at Baylor Scott & White Health) discuss situational ... Show More
31m 48s
Jan 2024
Review of the Cardiac Arrhythmia Suppression Trial (CAST)
NEJM 1991;324:781-788Background A hallmark of post-myocardial infarction (MI) care in the 1980’s was the monitoring and suppression of premature ventricular contractions (PVCs) via use of antiarrhythmic drugs. The practice was based on pathophysiologic rationale that PVC burden i ... Show More
6m 58s
May 2023
301. Guidelines: 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure – Question #20 with Dr. Robert Mentz
The following question refers to Sections 7.3.2, 7.3.8, and 7.6.2 of the 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. The question is asked by Palisades Medical Center medicine resident & CardioNerds Intern Dr. Maryam Barkhordarian, answered first by Hopkins B ... Show More
11m 3s
Sep 2023
333. Cardio-Oncology: Thromboembolic Disease in Cardio-oncology with Dr. Joshua Levenson
In this episode, CardioNerds Dr. Daniel Ambinder, Dr. Giselle Suero Abreu, and Dr. Saahil Jumkhawala discuss thromboembolic disease in cardio-oncology with faculty expert Dr. Joshua Levenson, the Associate Program Director of the cardiology fellowship and an Assistant Professor o ... Show More
50m 50s